X. Li
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 20
- Cancer Immunotherapy and Biomarkers 13
- Lung Cancer Research Studies 10
- Colorectal Cancer Treatments and Studies 6
- Peptidase Inhibition and Analysis 4
-
- Lung Cancer Treatments and Mutations 14
- Lung Cancer Diagnosis and Treatment 3
- Advanced Breast Cancer Therapies 2
- Co-authors
- Jian Fang (7 shared papers)Ying Cheng (5 shared papers)Jiuwei Cui (2 shared papers)G. Chen (6 shared papers)Yajie Zhao (3 shared papers)Shun Lü (2 shared papers)Shundong Cang (2 shared papers)Lin Wu (2 shared papers)
- Journals
- Annals of Oncology (16 papers)Journal of Thoracic Oncology (5 papers)ESMO Open (3 papers)Journal of Orthopaedic Surgery and Research (2 papers)Acta Biochimica et Biophysica Sinica (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
X. Li
33 papers receiving 219 citations
Peers
Comparison fields: 5 of 40
- Oncology 124
- Pulmonary and Respiratory Medicine 78
- Cancer Research 15
- Immunology 21
- Pathology and Forensic Medicine 16
Countries citing papers authored by X. Li
This map shows the geographic impact of X. Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by X. Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites X. Li more than expected).
Fields of papers citing papers by X. Li
This network shows the impact of papers produced by X. Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by X. Li. The network helps show where X. Li may publish in the future.
Co-authors
The 25 scholars most cited alongside X. Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 26 | |
| 2 | 2023 | 20 | |
| 3 | 2021 | 16 | |
| 4 | 2019 | 12 | |
| 5 | 2021 | 12 | |
| 6 | 2023 | 12 | |
| 7 | 2024 | 11 | |
| 8 | 2022 | 10 | |
| 9 | 2020 | 10 | |
| 10 | 2021 | 10 | |
| 11 | 2020 | 7 | |
| 12 | 2024 | 6 | |
| 13 | 2021 | 6 | |
| 14 | 2019 | 6 | |
| 15 | 2023 | 5 | |
| 16 | 2022 | 5 | |
| 17 | 2019 | 5 | |
| 18 | 2024 | 5 | |
| 19 | 2022 | 4 | |
| 20 | 2022 | 4 |
About X. Li
X. Li is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Pharmacology and Pathology and Forensic Medicine, having authored 34 papers that have together received 222 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (14 papers), Cancer Immunotherapy and Biomarkers (13 papers), Lung Cancer Research Studies (10 papers), Colorectal Cancer Treatments and Studies (6 papers), Peptidase Inhibition and Analysis (4 papers), Lung Cancer Diagnosis and Treatment (3 papers), Cancer therapeutics and mechanisms (3 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Oncology (124 citations), Pulmonary and Respiratory Medicine (78 citations), Cancer Research (15 citations), Immunology (21 citations) and Pathology and Forensic Medicine (16 citations). X. Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Jian Fang, Ying Cheng, Jiuwei Cui, G. Chen, Yajie Zhao, Shun Lü, Shundong Cang, Lin Wu, Yueyin Pan and Chunmei Bai. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, ESMO Open, Journal of Orthopaedic Surgery and Research and Acta Biochimica et Biophysica Sinica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.